Cargando…
A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)
The recent emergence of the novel coronavirus (SARS-CoV-2) has resulted in a devastating pandemic with global concern. However, to date, there are no regimens to prevent and treat SARS-CoV-2 virus. There is an urgent need to identify novel leads with anti-viral properties that impede viral pathogene...
Autores principales: | Zeng, Mao-Sen, Yu, Wen-Di, Wang, Hui-Xian, Liu, Jin-Yuan, Xu, Pei-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183004/ https://www.ncbi.nlm.nih.gov/pubmed/34111482 http://dx.doi.org/10.1016/j.ijbiomac.2021.06.017 |
Ejemplares similares
-
Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012) -
Synthetic Peptides
That Antagonize the Angiotensin-Converting
Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor
Binding Spike Protein
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2021) -
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015) -
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
por: Borkotoky, Subhomoi, et al.
Publicado: (2022) -
The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)